New drug combo aims to shrink advanced lung tumors

NCT ID NCT06448754

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new drug called volrustomig, when given alongside standard chemotherapy, is safe and can help control advanced non-small cell lung cancer. It will involve about 180 people whose cancer has spread and who have not yet received treatment for the advanced stage. The main goals are to see how well the combination shrinks tumors and to monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Los Angeles, California, 90067, United States
Research Site
RECRUITING

Grand Junction, Colorado, 81501, United States
Research Site
RECRUITING

Wheat Ridge, Colorado, 80033, United States
Research Site
WITHDRAWN

Baltimore, Maryland, 21231, United States
Research Site
WITHDRAWN

Detroit, Michigan, 48202, United States
Research Site
RECRUITING

Chapel Hill, North Carolina, 27514, United States
Research Site
WITHDRAWN

Tacoma, Washington, 98405, United States
Research Site
WITHDRAWN

Montreal, Quebec, H4A 3J1, Canada
Research Site
RECRUITING

Beijing, 100730, China
Research Site
RECRUITING

Hangzhou, 310014, China
Research Site
RECRUITING

Jinan, 250013, China
Research Site
RECRUITING

Yantai, 264000, China
Research Site
RECRUITING

Zhengzhou, 450000, China
Research Site
RECRUITING

Bois-Guillaume, 76031, France
Research Site
RECRUITING

Caen, 14076, France
Research Site
WITHDRAWN

Créteil, 94000, France
Research Site
RECRUITING

Dijon, 21079, France
Research Site
RECRUITING

Montpellier, 34070, France
Research Site
RECRUITING

Batumi, 6010, Georgia
Research Site
RECRUITING

Tbilisi, '0159, Georgia
Research Site
RECRUITING

Tbilisi, 0112, Georgia
Research Site
RECRUITING

Tbilisi, 0114, Georgia
Research Site
RECRUITING

Tbilisi, 0144, Georgia
Research Site
RECRUITING

Tbilisi, 186, Georgia
Research Site
NOT_YET_RECRUITING

Athens, 115 27, Greece
Research Site
RECRUITING

Athens, 12462, Greece
Research Site
RECRUITING

Elaiones, 546 23, Greece
Research Site
RECRUITING

Piraeus, 185 47, Greece
Research Site
RECRUITING

Thessaloniki, 57001, Greece
Research Site
RECRUITING

Genoa, 16132, Italy
Research Site
RECRUITING

Meldola, 47014, Italy
Research Site
RECRUITING

Milan, 20133, Italy
Research Site
RECRUITING

Naples, 80131, Italy
Research Site
RECRUITING

Orbassano, 10043, Italy
Research Site
RECRUITING

Perugia, 06132, Italy
Research Site
RECRUITING

Rozzano, 20089, Italy
Research Site
RECRUITING

Udine, 33100, Italy
Research Site
RECRUITING

Verona, 37134, Italy
Research Site
RECRUITING

Kuala Lumpur, 59100, Malaysia
Research Site
RECRUITING

Kuching, 93586, Malaysia
Research Site
RECRUITING

Perai, 13700, Malaysia
Research Site
RECRUITING

Lisbon, 1169-050, Portugal
Research Site
RECRUITING

Lisbon, 1400-038, Portugal
Research Site
WITHDRAWN

Lisbon, 1500-458, Portugal
Research Site
RECRUITING

Lisbon, 1649-035, Portugal
Research Site
RECRUITING

Porto, 4099-001, Portugal
Research Site
WITHDRAWN

Porto, 4100-180, Portugal
Research Site
RECRUITING

Cluj-Napoca, 400641, Romania
Research Site
RECRUITING

Craiova, 200542, Romania
Research Site
RECRUITING

Floreşti, 407280, Romania
Research Site
WITHDRAWN

Belgrade, 11000, Serbia
Research Site
RECRUITING

Belgrade, 11000, Serbia
Research Site
RECRUITING

Kamenitz, 21204, Serbia
Research Site
RECRUITING

Kragujevac, 34000, Serbia
Research Site
COMPLETED

Seongnam, 13620, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 06591, South Korea
Research Site
RECRUITING

Suwon, 16247, South Korea
Research Site
RECRUITING

A Coruña, 15009, Spain
Research Site
RECRUITING

Alcorcón, 28922, Spain
Research Site
RECRUITING

Barcelona, 08041, Spain
Research Site
RECRUITING

Madrid, 28041, Spain
Research Site
RECRUITING

Málaga, 29004, Spain
Research Site
RECRUITING

Pamplona, 31008, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
RECRUITING

Santiago de Compostela, 15706, Spain
Research Site
RECRUITING

Valencia, 46015, Spain
Research Site
RECRUITING

Valencia, 46026, Spain
Research Site
WITHDRAWN

Basel, 4031, Switzerland
Research Site
RECRUITING

Geneva, 1205, Switzerland
Research Site
RECRUITING

Lausanne, 1011, Switzerland
Research Site
RECRUITING

Winterthur, 8401, Switzerland
Research Site
RECRUITING

Zurich, 8091, Switzerland
Research Site
RECRUITING

Changhua, 50006, Taiwan
Research Site
RECRUITING

New Taipei City, 23561, Taiwan
Research Site
RECRUITING

Taipei, 106, Taiwan
Research Site
RECRUITING

Taipei, 110, Taiwan

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER